LINEZOLID PANPHARMA INJECTION linezolid 600 mg in 300 mL solution for injection infusion bag Australia - englanti - Department of Health (Therapeutic Goods Administration)

linezolid panpharma injection linezolid 600 mg in 300 ml solution for injection infusion bag

panpharma australia pty ltd - linezolid, quantity: 600 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

LINEZOLID PANPHARMA INJECTION linezolid 400 mg in 200 mL solution for injection infusion bag Australia - englanti - Department of Health (Therapeutic Goods Administration)

linezolid panpharma injection linezolid 400 mg in 200 ml solution for injection infusion bag

panpharma australia pty ltd - linezolid, quantity: 400 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

LINEZOLID PANPHARMA INJECTION linezolid 200 mg in 100 mL solution for injection infusion bag Australia - englanti - Department of Health (Therapeutic Goods Administration)

linezolid panpharma injection linezolid 200 mg in 100 ml solution for injection infusion bag

panpharma australia pty ltd - linezolid, quantity: 200 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Linezolid Clonmel 2mg/ml solution for infusion Irlanti - englanti - HPRA (Health Products Regulatory Authority)

linezolid clonmel 2mg/ml solution for infusion

clonmel healthcare ltd - linezolid - solution for infusion - 2 milligram(s)/millilitre - other antibacterials; linezolid - antibacterials for systemic use - linezolid clonmel is indicated in adults for the treatment of community acquired pneumonia and nosocomial pneumonia when known or suspected to be caused by susceptible gram positive bacteria. in determining whether linezolid clonmel is an appropriate treatment, the results of microbiological tests or information on the prevalence of resistance to antibacterial agents among gram positive bacteria should be taken into consideration

Linezolid Krka 600 mg film-coated tablets Irlanti - englanti - HPRA (Health Products Regulatory Authority)

linezolid krka 600 mg film-coated tablets

krka, d.d., novo mesto - linezolid - film-coated tablet - 600 milligram(s) - other antibacterials; linezolid - antibacterials for systemic use, other antibacterials - linezolid krka is indicated in adults for the treatment of community acquired pneumonia and nosocomial pneumonia when known or suspected to be caused by susceptible gram positive bacteria. in determining whether linezolid krka is an appropriate treatment, the results of microbiological tests or information on the prevalence of resistance to antibacterial agents among gram positive bacteria should be taken into consideration

LINEZOLID KABI linezolid 600 mg/300 mL solution for injection infusion bottle Australia - englanti - Department of Health (Therapeutic Goods Administration)

linezolid kabi linezolid 600 mg/300 ml solution for injection infusion bottle

fresenius kabi australia pty ltd - linezolid, quantity: 2 mg/ml - injection, intravenous infusion - excipient ingredients: sodium citrate; sodium hydroxide; glucose monohydrate; citric acid; hydrochloric acid; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram-positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

LINEZOLID KABI linezolid 600 mg/300 mL solution for injection infusion bag Australia - englanti - Department of Health (Therapeutic Goods Administration)

linezolid kabi linezolid 600 mg/300 ml solution for injection infusion bag

fresenius kabi australia pty ltd - linezolid, quantity: 2 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; sodium citrate; citric acid; sodium hydroxide; water for injections; glucose monohydrate - linezolid is indicated for the treatment of suspected or proven infections due to gram-positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

LINEZOLID AMNEAL linezolid 600 mg tablet blister pack Australia - englanti - Department of Health (Therapeutic Goods Administration)

linezolid amneal linezolid 600 mg tablet blister pack

amneal pharma australia pty ltd - linezolid -

Linezolid Teva 600mg Film-coated Tablets Malta - englanti - Medicines Authority

linezolid teva 600mg film-coated tablets

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - linezolid - film-coated tablet - linezolid 600 mg - antibacterials for systemic use

LINEZOLID Irlanti - englanti - HPRA (Health Products Regulatory Authority)

linezolid

generics (uk) limited - linezolid - solution for infusion - 2 mg/ml - linezolid